Mechanisms of Lipid Droplet Protein Targeting
Mechanisms of Lipid Droplet Protein Targeting
批准号:
9895819
负责人:
Tobias C Walther
金额:
$34.15万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-30 至 2020-11-30
关键词:
AddressAtherosclerosisBindingBinding ProteinsBiochemistryBiological ModelsBiologyBiophysicsCell physiologyCellular biologyChlamydiaCoat Protein Complex IComputational TechniqueCoronary heart diseaseCrowdingCytoplasmCytosolDiseaseDrosophila genusEmulsionsEnzymesEstrogen receptor positiveFamilial generalized lipodystrophyFatty LiverGoalsGrantGrowthHealthHepatitis C virusHomeostasisHumanHydrophobicityHyperlipidemiaInfectionIntegral Membrane ProteinInterventionLecithinLifeLipidsLipodystrophyLiver diseasesMammalian CellMediatingMembraneMembrane LipidsMembrane ProteinsMetabolicMetabolic DiseasesMetabolic syndromeMetabolismModelingMolecularMutationNon-Insulin-Dependent Diabetes MellitusObesityOrganellesPathologyPhasePhospholipidsPhosphorylcholinePhysicsPlayProteinsProteomeProteomicsReadingResearchRiskRoleSpecificitySurfaceTestingTherapeuticTriglyceridesVariantVirus DiseasesWorkaqueouscancer cachexiacombatinnovationlipid Ilipid metabolismmembrane synthesismonolayernon-alcoholic fatty liver diseaseobesity treatmentpathogentherapeutic developmenttraffickingtreatment site
中文摘要
项目摘要
细胞代谢能量以中性脂的形式储存,特别是三酰甘油(TGS),它是
包装在细胞质脂滴(LDS)中。LDS的过度积累发生在
许多疾病,包括肥胖、2型糖尿病、动脉粥样硬化和代谢综合征。此外,LDS
在某些感染中发挥关键作用,包括丙型肝炎病毒和衣原体,通过促进某些病毒的复制
病原体。
尽管它们在人类健康和疾病中发挥着重要作用,但令人惊讶的是,人们对LDS知之甚少。LDS包括
被磷脂单分子层包围的疏水核心。LDS的大部分功能,包括TG合成,
甘油三酯的储存和能量动员是由这些表面蛋白执行和调节的。这些是如何
然而,蛋白质是针对LDS的,目前仍不清楚。在细胞器中,LD是独一无二的
因为它们的表面位于疏水相(LD芯)和水相(LD芯)的交界处
细胞质),因此不能容纳典型的具有球状结构域的跨膜蛋白。
因此,蛋白质靶向LDS必须涉及到独特的机制。
在这个项目中,我们将确定蛋白质是如何特定地定位于LDS表面的。我们会
研究包括GPAT4和其他酶在内的甘油三酯酶如何重新定位到LDS,使它们能够生长。在……里面
此外,我们还将确定包含两亲性螺旋的蛋白质,包括限速
磷脂酰胆碱酶CTP:磷酸胆碱胞苷转移酶(CCT),是针对
LDS的表面从胞浆中脱出,便于扩张。对于项目的每个部分,我们都将使用尖端技术
生物物理、生物化学、细胞生物学、蛋白质组学和计算技术,并验证我们在
不同的模型系统,如果蝇和哺乳动物细胞。尽管这里提出的研究是
基础,驱动脂滴蛋白靶向的基本细胞机制的确定将
然而,促进制定治疗战略,以抗击肥胖、代谢性疾病和
病毒感染,以及推动对这些细胞器细胞生物学的进一步研究。
英文摘要
Project Summary
Cellular metabolic energy is stored in the form of neutral lipids, particularly triacylglycerols (TGs), which are
packaged in cytoplasmic lipid droplets (LDs). Excessive accumulation of LDs occurs during the progression of
many diseases, including obesity, type 2 diabetes, atherosclerosis and metabolic syndrome. In addition, LDs
play a key role in some infections, including hepatitis C virus and chlamydia, by facilitating replication of some
pathogens.
Despite their important role in human health and disease, surprisingly little is known about LDs. LDs consist of
a hydrophobic core surrounded by a phospholipid monolayer. Most functions of LDs, including TG synthesis,
TG storage, and energy mobilization, are executed and regulated by these surface proteins. How these
proteins are specifically targeted to LDs, however, remains unclear. Among organelles, LDs are unique
because their surface is at the interface of a hydrophobic phase (the LD core) and an aqueous phase (the
cytoplasm) and thus are unable to accommodate typical transmembrane proteins with globular domains.
Therefore, the targeting of proteins to LDs must involve unique mechanisms.
In this project, we will determine how proteins are specifically targeted to the surface of LDs. We will
investigate how triglyceride enzymes including GPAT4 and others re-localize to LDs, enabling their growth. In
addition, we will determine how amphipathic helix-containing proteins, including the rate-limiting
phosphatidylcholine enzyme CTP:phosphocholine cytidylyltransferase (CCT), are specifically targeted to the
surface of LDs from the cytosol to facilitate expansion. For each part of the project, we will use cutting-edge
biophysics, biochemistry, cell biology, proteomics and computational techniques and validate our findings in
different model systems such as Drosophila and mammalian cells. Although the research proposed here is
basic, the determination of the fundamental cellular mechanisms that drives lipid droplet protein targeting will
nevertheless facilitate the development of therapeutic strategies to combat obesity, metabolic diseases and
viral infections, as well as propel further research into the cell biology of these organelles.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FASEB SRC on Lipid Droplets: Metabolic Consequences of the Storage of Neutral Lip
-
批准号:8781623
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2014
-
负责人:Tobias C Walther
-
依托单位:
Cellular Functions of Plasma Membrane Organization by Eisosomes
-
批准号:8890991
-
项目类别:
-
资助金额:$5.65万
-
财政年份:2012
-
负责人:Tobias C Walther
-
依托单位:
Cellular Functions of Plasma Membrane Organization by Eisosomes
-
批准号:8776315
-
项目类别:
-
资助金额:$30.69万
-
财政年份:2012
-
负责人:Tobias C Walther
-
依托单位:
Cellular Functions of Plasma Membrane Organization by Eisosomes
-
批准号:8235451
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2012
-
负责人:Tobias C Walther
-
依托单位:
Cellular Functions of Plasma Membrane Organization by Eisosomes
-
批准号:8426106
-
项目类别:
-
资助金额:$30.48万
-
财政年份:2012
-
负责人:Tobias C Walther
-
依托单位:
Mechanisms of Lipid Droplet Protein Targeting
-
批准号:10524777
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2011
-
负责人:Tobias C Walther
-
依托单位:
Mechanisms of Lipid Droplet Protein Targeting
-
批准号:9027142
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2011
-
负责人:Tobias C Walther
-
依托单位:
Mechanisms of Lipid Droplet Protein Targeting
-
批准号:9145416
-
项目类别:
-
资助金额:$35.62万
-
财政年份:2011
-
负责人:Tobias C Walther
-
依托单位:
Mechanisms of Lipid Droplet Protein Targeting
-
批准号:8080650
-
项目类别:
-
资助金额:$41.4万
-
财政年份:2011
-
负责人:Tobias C Walther
-
依托单位:
Mechanisms of Lipid Droplet Protein Targeting
-
批准号:8738798
-
项目类别:
-
资助金额:$6.32万
-
财政年份:2011
-
负责人:Tobias C Walther
-
依托单位:
Mechanisms of Lipid Droplet Protein Targeting
-
批准号:8725690
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2011
-
负责人:Tobias C Walther
-
依托单位:
Mechanisms of Lipid Droplet Protein Targeting
-
批准号:10322126
-
项目类别:
-
资助金额:$29.89万
-
财政年份:2011
-
负责人:Tobias C Walther
-
依托单位:
Mechanisms of Lipid Droplet Protein Targeting
-
批准号:10704249
-
项目类别:
-
资助金额:$4.35万
-
财政年份:2011
-
负责人:Tobias C Walther
-
依托单位:
Mechanisms of Lipid Droplet Protein Targeting
-
批准号:10052146
-
项目类别:
-
资助金额:$31.9万
-
财政年份:2011
-
负责人:Tobias C Walther
-
依托单位:
Mechanisms of Lipid Droplet Protein Targeting
-
批准号:8339464
-
项目类别:
-
资助金额:$41.52万
-
财政年份:2011
-
负责人:Tobias C Walther
-
依托单位:
Mechanisms of Lipid Droplet Protein Targeting
-
批准号:8537217
-
项目类别:
-
资助金额:$40.17万
-
财政年份:2011
-
负责人:Tobias C Walther
-
依托单位:
海外基金